Document is current
Any future updates will be listed below
-
Authors
Nerattini, Matilde https://orcid.org/0000-0002-1182-4748
Berti, Valentina
Matthews, Dawn C.
Williams, Schantel
Andy, Caroline
Fauci, Francesca
Boneu, Camila
Ajila, Trisha
Pahlajani, Silky
Battista, Michael
Andrews, Randolph
Pupi, Alberto
Osborne, Joseph R.
Fink, Matthew
Brinton, Roberta Diaz
Dyke, Jonathan P.
Mosconi, Lisa
-
Funding
Funding for this research was provided by:
Università degli Studi di Firenze
- License Information
-
More Information
Article History
Received: 6 May 2025
Accepted: 13 July 2025
First Online: 7 August 2025
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. All participants gave written informed consent to participate in this 18F-FES PET study, which was approved by the WCM Institutional Review Board. Use of 18F-FES was carried out under WCM Radioactive Drug Research Committee and National Cancer Institute (NCI) Investigational New Drug (IND) #146703 approval.
: The authors have no relevant financial or non-financial interests to disclose.
